Stereotypic Behaviors and Feeding Difficulties in Adults With Developmental Disabilities
Launched by OSLO UNIVERSITY HOSPITAL · Apr 8, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how behavioral interventions can help adults with developmental disabilities (DD) and autism who experience challenging behaviors, like stereotypic movements and feeding difficulties. These issues can affect their health and quality of life, making it harder for them to participate in their communities, go to school, or find jobs. The research aims to find effective ways to support these individuals in becoming more independent and improving their overall well-being.
To participate in the trial, individuals need to be at least 18 years old and have a diagnosis of a developmental disability or autism. They will be recruited from the Department of Neurohabilitation or other hospitals in the Oslo area. Participants can expect to receive specialized care and support aimed at addressing their specific behavioral challenges. It's important to note that those with medical issues causing their behavior problems or those receiving inadequate care may not be eligible to join the study. This trial is currently recruiting participants, and all genders are welcome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants will be recruited through referrals at the Department of Neurohabilitation, or from other hospitals in the Oslo Region.
- • be 18 years or older,
- • have a DD, autism spectrum disorder or a PDD-NOS diagnosis
- • and be referred to the specialist habilitation service for adults.
- Exclusion Criteria:
- • If there are medical causes of the participant's behavioral problem or
- • a reasonable possibility that the referred problem is caused by medical variables
- • if the client participant receives communal care services and if those are not in accordance with Norwegian standards of services for individuals with DD.
- • This could include inappropriate staff-to-client ratio,
- • lack of stimulating activities,
- • or if on-site training is insufficient.
- • the exclusion criteria do not exclude health care from The Oslo University Hospital.
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Petur I Petursson, MS, BCBA
Principal Investigator
Oslo University Hospital
Sigmund Eldevik, PhD, BCBA-D
Study Chair
Oslo Metropolitan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported